PTGX Exercise Disclosure
Patel Dinesh V Ph D · SEC Form 4 · Filed Sep 10, 2026
Exercise
Calculated transaction value
$0
Patel Dinesh V Ph D President And CEO
PTGX
Transaction date
Sep 8, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 3 days later
PTGX daily price context
Close on/before transaction
$145.94
Sep 8, 2026
Close before public filing
$145.16
Sep 10, 2026
Return since public filing
+2.08%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 54,174 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-106831
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$20.94M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 10, 2026 | $157.06K |
| Protagonist Therapeutics, Inc PTGX | Sale | Sep 10, 2026 | $1.05M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 10, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Sale | Sep 9, 2026 | $9.29M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 9, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 9, 2026 | $1.37M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Sep 8, 2026 | $1.17M |
| Protagonist Therapeutics, Inc PTGX | Sale | Sep 8, 2026 | $7.9M |
| Protagonist Therapeutics, Inc PTGX Current | Exercise | Sep 8, 2026 | $0 |